Filters

Ceftizoxime manufacturers

Filters

Filters

Filters , active

Country of origin : China
None products found

ceftizoxime

Vials 0.5 g, 0.75 g, 1 g, 1.5 g

Dossier type
CTD
Dossier status
Ready to file
Country of origin
China
GMP approvals
China
Manufacturer #38958
China-based pharmaceutical technology company engaged in development and manufacturing of Rx pharmaceutical products and drug intermediates. Focuses on supplying quality raw materials and finished dosage forms for domestic and international markets. Operates production lines aligned with domestic GMP standards and select export requirements.

Manufacturer usually replies in 24 days

ceftizoxime

Injection 0.5 g, 1 g

Dossier type
CTD
Dossier status
Ready to file
Country of origin
China
GMP approvals
China
Manufacturer #38955
Established in the 1990s, this Chinese pharmaceutical manufacturer brings three decades of Rx injectable and oral formulation production experience. Portfolio of APIs, intermediates, and finished dosage forms spans oncology, cardiovascular, and metabolic therapy areas. International GMP certifications support export to regulated global markets.

Manufacturer usually replies in 51 days

ceftizoxime

Injection 1 g

Dossier type
CTD
Dossier status
Ready to file
Country of origin
China
GMP approvals
China
Manufacturer #21649

Established in 2001, this manufacturer is a leading CTD dossier owner and manufacturer with a strong global presence. As a GMP manufacturer, it adheres to strict international standards, operating advanced production lines for cardiovascular, anti-infective, and oncology drugs. Products from this CTD dossier owner and manufacturer are sold in over 30 countries, supported by a large workforce and comprehensive R&D capabilities. The manufacturer demonstrates consistent compliance as both a GMP manufacturer and CTD dossier owner and manufacturer.

 

Manufacturer usually replies in 17 days

Want to see all products?

Subscribe today to benefit from:

  • Streamlined product sourcing - the leading CTD dossiers database focused on finished dosage formulations

  • Direct negotiations - connect and negotiate directly with manufacturers without any brokerage fee

  • Increased profitability - secure the best commercial terms for your business by comparing offers from several manufacturers

Request Subscription

Willing to unlock more features?

Please fill out form and send us your specific requirements, and we will get back to you as soon as possible

Want unlimited access to the Pipelinepharma database?

Become a subscriber to unlock:

  • Streamlined product sourcing: access the only CTD dossier pipeline and sourcing platform.

  • Direct connections: communicate directly with CTD dossier owners and manufacturers with no brokerage fees.

  • Higher profitability: compare multiple supplier offers and secure the best commercial terms.

  • Expanded network: view supplier portfolios and stay updated on new products.

  • Value-added product ideas: discover products with lower competition potential.

  • Access to marketing authorizations for sale: find already registered products in your target markets.